The Food and Drug Administration has new tools to hold drug companies accountable for promises they make about medications. But the agency has yet to show its hand in using this new power.
Moderna said people without insurance will be able to get its COVID vaccine at no cost after the U.S. government bows out. But patients will have to use the company’s cumbersome assistance program.
Treating cholera has been a passion for Bangladeshi scientist Firdausi Qadri. She reflects on her career and inspirations, cholera’s scourge, as well as successes in combating the disease.
NPR’s Ailsa Chang talks with Eli Lilly CEO David Ricks about the company’s move to reduce prices on some older insulins and cap how much people have to pay out of their own pocket.
An insulin maker is cutting its prices. Eli Lilly, one of the three makers of insulin products in the United States, is also making other moves toward affordability for people with diabetes.
The Institute for Sexual Research, founded in 1919, pioneered modern gender-affirming health care. NPR’s Ailsa Chang speaks with medical historian Brandy Schillace on this piece of queer history.
Depending on where they lived, demands for repayment can drain the assets that a patient on Medicaid leaves behind after they die. Iowa aggressively collects “clawback” funds.
Millions of people who depend on the Supplemental Nutrition Assistance Program known as SNAP will see a cut of $90 a month or more. Some recipients say it will make it harder to buy healthy food.
When Lauren Miller found out one of her twins had a fatal condition, she discovered her doctors in Texas would only say: You need to leave the state. She went to Colorado for a selective reduction.
Billing experts and lawmakers are playing catch-up as providers get around new consumer protections, leaving patients like Danielle Laskey of Washington state with big bills for emergency care.